IQM appoints CTO and Chief Scientist ahead of Nasdaq listing
IQM Quantum Computers appointed Dr. Craig Ciesla as Chief Technology Officer and Dr. Inés de Vega as Chief Scientist to bolster its leadership team. The appointments support the company's planned Nasdaq listing via a merger with Real Asset Acquisition Corp., backed by a $146 million PIPE. IQM has sold 23 quantum computers and operates as a vertically integrated quantum computing firm.

*this image is generated using AI for illustrative purposes only.
IQM Quantum Computers has appointed Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist to strengthen its leadership team. The appointments come as the company prepares for a planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (NASDAQ: RAAQ). These strategic hires aim to advance IQM's technology roadmap and support its scaling as a fully vertically integrated quantum computing company.
Dr. Ciesla brings over 25 years of experience in deep tech, having delivered products across industries from startups to Fortune 500 companies. He will advance IQM's technology strategy and drive its implementation into systems and products. An accomplished innovator, Ciesla is an inventor of more than 100 patents and patent applications. He most recently served as Vice President of Engineering at 10x Genomics (NASDAQ: TXG) and held leadership roles at Illumina (NASDAQ: ILMN), Lumentum (NASDAQ: JDSU), Intel (NASDAQ: INTC), and Tactus Technology.
Dr. de Vega transitions from her role as Vice President of Quantum Solutions to become Chief Scientist. With over 20 years of experience, she will ensure scientific feasibility and system-level consistency across IQM's technology. Her career includes leading teams in developing quantum algorithms and advanced error-correction tools. She has also been a researcher at academic institutions such as the Max Planck Institute of Quantum Optics, the University of Ulm, and the Ludwig Maximilian University of Munich.
Jan Goetz, CEO and Co-founder of IQM Quantum Computers, highlighted the value of the new appointments. "Ciesla's track record of scaling complex instrumentation platforms and building world-class R&D organizations makes him an exceptional addition to our leadership team," Goetz said. "As we accelerate our path toward fault-tolerant quantum computing, his experience integrating hardware and software systems at scale will be invaluable."
The leadership changes coincide with IQM's operational growth and its upcoming public market debut. The company operates its own chip factory and assembly line and has sold 23 quantum computers to date. The planned merger with Real Asset Acquisition Corp. has gained momentum, securing an upsized PIPE of $146 million in early June with participation from Finnish pension insurer Ilmarinen and existing institutional investors.
Key Appointments
| Name | New Role | Previous Experience |
|---|---|---|
| Dr. Craig Ciesla | Chief Technology Officer | VP of Engineering, 10x Genomics; Leadership roles at Illumina, Intel |
| Dr. Inés de Vega | Chief Scientist | VP of Quantum Solutions, IQM Quantum Computers |
How will the new leadership team influence IQM's technology roadmap post-merger?
What impact will the Nasdaq listing have on IQM's ability to scale operations?
How might the appointments affect investor confidence in the upcoming merger?





























